Sort
48,018 grants matching “immunotherapy”
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
$617,031Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2024 · CA
TOX-driven CD8 T cell differentiation and dysfunction in tumors
$617,017Andrea Schietinger · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Project 1: Durable impact of COVID on innate and adaptive immunity
$616,990Michela Locci · Massachusetts General Hospital · U19 · FY2024 · AI
Molecular Targeted Photoimmunotherapy for Bladder Cancer
$616,957Piyush Agarwal · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Leadership, Planning and Evaluation
$616,942Steven E Artandi · Stanford University · P30 · FY2022 · CA
Neuro-immune modulation of pain in health and disease
$616,920Christopher Ryan Donnelly · Duke University · R01 · FY2022 · DE
Synthetic Compartments to Rewire Inflammatory Signaling and Augment Immune Cell Function
$616,897Matthew Charlton Good · University Of Pennsylvania · R56 · FY2025 · EB
Outcomes for CLL patients treated with novel therapy
$616,831Neil E Kay · Mayo Clinic Rochester · R01 · FY2022 · CA
Evaluation of novel treatments in biochemically recurrent prostate
$616,806Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Development of multinuclear MRI for image guided therapy of glioma patients
$616,798Ovidiu C Andronesi · Massachusetts General Hospital · R01 · FY2023 · CA
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer
$616,757Maximilian Diehn · Stanford University · R01 · FY2023 · CA
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer
$616,753Maximilian Diehn · Stanford University · R01 · FY2022 · CA
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis
$616,751Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2025 · CA
Microbial-inspired immune-stimulating antibody-toxin conjugate (ATC) for cancer immunotherapy
$616,715Betty Kim · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Low dose IL-2 and human regulatory T cells
$616,712Thomas R Malek · University Of Miami School Of Medicine · R01 · FY2018 · AI
DESIGNING EFFECTIVE ADOPTIVE IMMUNOTHERAPY FOR HIGH-RISK PEDIATRIC MEDULLOBLASTOMA VIA A RATIONAL COMBINATION WITH MRI-GUIDED FOCUSED ULTRASOUND
$616,710Children'S Research Institute · · FY2024 · Defense Health Agency
Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions
$616,686Jin Zhang · University Of California, San Diego · R01 · FY2024 · CA
Immune correlates of acute HBV recovery with and without HIV
$616,491Chloe L Thio · Johns Hopkins University · R01 · FY2018 · AI
Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation
$616,432Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
$616,381Cheng Zhu · Georgia Institute Of Technology · U01 · FY2023 · CA
Novel Transgenic Mouse Models Addressing Outstanding Translational Barriers in Antibody-Based Therapeutics
$616,273Stylianos Bournazos · Rockefeller University · R01 · FY2021 · CA
Spatially resolved, single cell biomarkers of B cell lymphoma
$616,249Akil Merchant · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer
$616,121James S Duncan · Yale University · R01 · FY2022 · CA
First-in-Class CD206 Agonist for Immunologically Cold Solid Organ Cancers
$616,056Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$615,955Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA